Background: The inflammatory bowel disease (IBD) is a chronic lifelong inflammation that
may affect the entire gastro-intestinal tract in Crohn's disease and the colon in ulcerative …

Background Tight and personalised control of inflammatory bowel disease in a traditional
setting is challenging because of the disease complexity, high pressure on outpatient clinics …

Widely varying prevalence rates of oral lesions in patients with Crohn's disease have been
reported, ranging from 0.5% to 37%. These manifestations may coincide with or precede …

Background Elderly onset (EO) inflammatory bowel disease (IBD) may become a more
common entity as a result of population aging and the rising IBD incidence. Its management …

Objectives: Medical treatment options and strategies for Crohn's disease (CD) have
changed over the past decades. To assess its impact, we studied the evolution of the long …

Immunoglobulin A (IgA) is acknowledged to play a role in the defence of the mucosal barrier
by coating microorganisms. Surprisingly, IgA-deficient humans exhibit few infection-related …

Background & Aims Telemedicine can be used to monitor determinants and outcomes of
patients with chronic diseases, possibly increasing the quality and value of care …

Microbiota composition and its metabolic capacity are very important for host health.
Evidence suggests that gut microbiome is involved in the metabolites production by host …

Monitoring mucosal inflammation is crucial to prevent complications and disease
progression in Crohn's disease (CD). Endoscopy is the current standard, but is invasive …

Background Microbial shifts have been associated with disease activity in Crohn's disease
[CD], but findings on specific taxa are inconsistent. This may be due to differences in applied …